BioSpace News Archive

The need for freeze-drying has become a necessity across the food and pharmaceutical industry, and this factor has driven demand within the global lyophilization equipment and services market.

Albany NY, United States: Veterinary weighing scales are essential devices in every veterinary clinic for the primary physical examination of animals.

Albany NY, United States: Synovial sarcoma is a predominantly juxta-articular, malignant, and soft-tissue tumour, which represents approximately 10% of all soft-tissue sarcomas.

Addex Therapeutics Ltd announced that patient enrollment has been completed in its Phase 2a clinical study evaluating dipraglurant as a potential treatment for blepharospasm, a type of dystonia characterized by involuntary contractions or spasms of the eyelid muscles.

International medical imaging IT and cybersecurity company Sectra has signed a contract with North York General Hospital in Canada.

Versantis announced that Innosuisse, the Swiss national innovation agency, will co-fund a project to develop a prototype portable point-of-care device for blood ammonia monitoring.

Molecular Targeting Technologies Inc. and ITM Isotope Technologies Munich SE announced the signing of a global clinical supply agreement that provides MTTI with ITM’s medical radioisotope no-carrier-added lutetium-177 for the preclinical and clinical development as well as potential commercial production of MTTI’s radiopharmaceutical candidate n.c.a.

Mallinckrodt plc announced the publication of findings from a retrospective chart review study assessing the real-world use and outcomes of INOmax® gas, for inhalation therapy in hospitalized patients with COVID-19 and mild-to-moderate acute respiratory distress syndrome, a disorder in which fluid leaks into the lungs, making breathing difficult or impossible.

SOPHiA GENETICS SA today announced it will release its financial results for the first quarter of fiscal 2022 before U.S. markets open on Tuesday, May 10, 2022.

Ikena Oncology, Inc. today announced the appointment of Jotin Marango, M.D., Ph.D., to Chief Financial Officer (CFO) and Head of Corporate Development.